170378 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates; Assays involving proteins of known structure or function as defined in the subgroups; Details Lipocortins
Anti-annexin A2 monoclonal antibodies
#2PLASMA BIOMARKER FOR OVARIAN CANCER
#3Anti-annexin A2 monoclonal antibodies
#4Free Functional Annexin Levels in Plasma as a Biomarker of Cardiovascular Risk
#5PLASMA BIOMARKER FOR OVARIAN CANCER
#6Diagnosis of benign and cancerous growths by measuring circulating tumor stem cells and serum AnnexinA2
#7Use of annexin A3 as a diagnostic and prognostic biomarker and therapeutic target for treating hepatocellular carcinoma
#8METHODS FOR THE DETECTION OF ESOPHAGEAL ADENOCARCINOMA
#9METHOD FOR DETECTINGAND/OR ASSAYING ANNEXIN A3 FROMA MAMMAL IN BLOOD OR AT LEAST ONE DERIVATIVE THEREOF
#10METHOD FOR DETECTING AND/OR ASSAYING ANNEXIN A3 FROM A MAMMAL IN BLOOD OR AT LEAST ONE DERIVATIVE THEREOF
#11Cell with surface coated with ANXA1 and use thereof
#12Polypeptide binding to annexin A1 and use thereof
#13Use of annexin A3 as a diagnostic and prognostic biomarker and therapeutic target for treating hepatocellular carcinoma
#14Method and a Kit To Detect Malignant Tumors and Provide a Prognosis
#15METHOD FOR AVOIDING INFLUENCE OF ENDOGENOUS LIPOPROTEIN AND REAGENT
#16METHOD FOR DIAGNOSIS NON-SMALL-CELL-LUNG-CARCINOMA (NSCLC) AND CLASSIFICATION OF ITS SUBTYPES WITH DIFFERENT COMBINATIONS OF 6 PROTEIN BIOMARKERS
#17Method and a Kit To Detect Malignant Tumors and Provide a Prognosis
#18Diagnosis of benign and cancerous growths by measuring circulating tumor stem cells and serum AnnexinA2
#19ANNEXIN A11 AND ASSOCIATED GENES AS BIOMARKERS FOR CANCER
#20METHOD FOR SCREENING CATTLE, CATTLE SCREENED, AND CATTLE SCREENING KIT
#21NOVEL ANTIBODIES RECOGNIZING NATIVE ANNEXIN A3
#22PCSK9 inhibitors and methods of use thereof
#23Detection of endometrial secretion markers for assessment of endometriosis
#24Annexin proteins and autoantibodies as serum markers for cancer
#25Annexin A3 for cancer diagnosis
#26USE OF BIOMARKERS FOR THE DIAGNOSIS AND PROGNOSIS OF LUNG CANCER
#27Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma
#28NOVEL PROTEINS WITH TARGETED BINDING
#29Protein scaffolds and uses thereof
#30Methods for detecting fetal cells in the maternal blood
#31Autoimmune regulation of prostate cancer by annexin A3
#32ANNEXIN II COMPOSITIONS FOR TREATING OR MONITORING INFLAMMATION OR IMMUNE-MEDIATED DISORDERS
#33USE OF FLOW-CYTROMETRIC ANALYSIS TO OPTIMIZE CELL BANKING STRATEGIES FOR CHO CELLS
#34ANNEXIN II COMPOSITIONS FOR TREATING OR MONITORING INFLAMMATION OR IMMUNE-MEDIATED DISORDERS
#35IDENTIFYING CORONARY OR SOFT TISSUE CALCIFICATION
#36Annexin-based apoptosis markers
#37Device for binding a target entity to a bait entity and detection methods using the same
#38Apo-3 ligand polypeptide
#39Annexin A3 for prostate cancer diagnosis
#40Overexpression of mammaglobin B in ovarian and endometrial tumors - a new diagnostic and therapeutic marker
#41Apo-3 ligand polypeptide
#42Annexin proteins and autoantibodies as serum markers for cancer
#43ANNEXIN PROTEINS AND AUTOANTIBODIES AS SERUM MARKERS FOR CANCER
#44Protein scaffolds and uses thereof
#45Use of flow-cytrometric analysis to optimize cell banking strategies for CHO cells
#46Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof
#47Assays for diagnosis of thrombophilic disease
#48Novel proteins with targeted binding